|
|
|
|
|
Last Trade
|
Last Trade:
$6.91
|
Change:
0.11 (1.62%)
|
Trade Time:
May 26
|
Market Cap:
$997.19M
|
|
|
|
|
|
|
Description of Business
|
|
We are advancing the field of immune medicine by harnessing the inherent biology
of the adaptive immune system to transform the diagnosis and treatment of
disease. We believe the adaptive immune system is nature's most finely tuned
diagnostic and therapeutic for most diseases, but the inability to decode it has
prevented the medical community from fully leveraging its capabilities. Our
immune medicine platform applies our proprietary technologies to read the
diverse genetic code of a patient's immune system and aims to understand
precisely how the immune system detects and treats disease in that patient. We
capture these insights in our dynamic clinical immunomics database, which is
underpinned by computational biology and machine learning, and use these
insights to develop and commercialize clinical products and services that we are
tailoring to each individual patient.
|
|
|
|